Key predictive factors for efficacy of axitinib in first-line metastatic renal cell carcinoma: subgroup analysis in Japanese patients from a randomized, double-blind phase II study

OBJECTIVES: To conduct Japanese subgroup analyses of a randomized, global Phase II study of axitinib with and without dose titration in first-line metastatic renal cell carcinoma and to explore predictive factors for axitinib efficacy in first-line metastatic renal cell carcinoma. METHODS: The data...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Yoshihiko, Fukasawa, Satoshi, Oya, Mototsugu, Uemura, Hirotsugu, Shinohara, Nobuo, Habuchi, Tomonori, Rini, Brian I., Chen, Ying, Bair, Angel H., Ozono, Seiichiro, Naito, Seiji, Akaza, Hideyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091032/
https://www.ncbi.nlm.nih.gov/pubmed/27572087
http://dx.doi.org/10.1093/jjco/hyw103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091032/
https://www.ncbi.nlm.nih.gov/pubmed/27572087
http://dx.doi.org/10.1093/jjco/hyw103

Ejemplares similares